对立的谱系特异因子在肺腺癌中诱导了一种亲瘤混合身份状态
bioRxiv : the preprint server for biology
|December 16, 2024
概括
癌细胞可以改变身份,推动瘤生长和抵抗力. 在肺腺癌中,HNF4α驱动增殖并创造混合身份,影响治疗反应.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌细胞生物学 癌细胞生物学
背景情况:
- 癌细胞表现出血统可塑性,改变其身份以促进瘤的进展和治疗耐药性.
- 肺腺癌 (LUAD) 的进展涉及肺系忠诚度的丧失和非肺性身份的获得,形成混合身份 (混合-ID) 状态.
- 在LUAD中驱动这些身份转移的分子机制尚未完全理解.
研究的目的:
- 在KRAS驱动的LUAD中识别瘤生长和身份转移的分子驱动因素.
- 阐明HNF4α在LUAD进展中的作用及其与NKX2-1.的相互作用.
- 研究RAS/MEK信号和HNF4α对LUAD细胞身份和治疗反应的影响.
主要方法:
- 研究了HNF4α在KRAS驱动的LUAD细胞系中的作用.
- 分析了HNF4α与正规目标的结合及其与NKX2-1.的相互作用.
- 研究了RAS/MEK通路抑制和HNF4α枯竭对细胞身份和基因表达的影响.
- 在HNF4α耗尽后对KRASG12D抑制的评估灵敏度.
主要成果:
- 肝细胞核因子4-α (HNF4α) 是胃肠道调节剂,在KRAS驱动的LUAD中驱动瘤生长和扩散.
- 通过激活其点和异常复合体与NKX2-1,HNF4α诱导了肠胃/肝脏类状态,扰乱了混合ID LUAD中的肺身份.
- 持续的RAS/MEK信号保持混合ID状态;其抑制促进肺部信号并增强NKX2-1染色体结合.
- HNF4α的减少增加了对KRASG12D向治疗的敏感性.
结论:
- 相反的谱系指标的共同表达,如HNF4α和NKX2-1,在LUAD中创建了一个混合身份状态.
- 这种混合身份驱动瘤的进展,并影响对向治疗的反应.
- 准HNF4α可能是克服LUAD抗性的治疗策略.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K


